Strand V - Search Results

1

Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study.

Buttgereit F, Strand V, Lee EB, Simon-Campos A, McCabe D, Genet A, Tammara B, Rojo R, Hey-Hadavi J. Buttgereit F, et al. Among authors: strand v. RMD Open. 2019 Apr 16;5(1):e000889. doi: 10.1136/rmdopen-2018-000889. eCollection 2019. RMD Open. 2019. PMID: 31168411 Free PMC article. Clinical Trial.

2

The future use of biologic therapies in combination for the treatment of rheumatoid arthritis.

Strand V. Strand V. J Rheumatol Suppl. 1996 Mar;44:91-6. J Rheumatol Suppl. 1996. PMID: 8833063 Review.

3

Recent advances in the treatment of rheumatoid arthritis.

Strand V. Strand V. Clin Cornerstone. 1999;2(2):38-50. doi: 10.1016/s1098-3597(99)90013-3. Clin Cornerstone. 1999. PMID: 10689543 Free article. Review.

4

Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritis.

Strand V, Cohen S, Crawford B, Smolen JS, Scott DL; Leflunomide Investigators Groups. Strand V, et al. Rheumatology (Oxford). 2004 May;43(5):640-7. doi: 10.1093/rheumatology/keh140. Epub 2004 Mar 23. Rheumatology (Oxford). 2004. PMID: 15039493 Clinical Trial.

5

Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years.

Strand V, Balbir-Gurman A, Pavelka K, Emery P, Li N, Yin M, Lehane PB, Agarwal S. Strand V, et al. Rheumatology (Oxford). 2006 Dec;45(12):1505-13. doi: 10.1093/rheumatology/kel358. Epub 2006 Oct 24. Rheumatology (Oxford). 2006. PMID: 17062648 Clinical Trial.

6

Randomized controlled trial design in rheumatoid arthritis: the past decade.

Strand V, Sokolove J. Strand V, et al. Arthritis Res Ther. 2009;11(1):205. doi: 10.1186/ar2555. Epub 2009 Jan 30. Arthritis Res Ther. 2009. PMID: 19232061 Free PMC article. Review.

7

Rheumatoid arthritis classification criteria - It's finally time to move on!

Sokolove J, Strand V. Sokolove J, et al. Among authors: strand v. Bull NYU Hosp Jt Dis. 2010;68(3):232-8. Bull NYU Hosp Jt Dis. 2010. PMID: 20969557 Free article. Review.

8

A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritis.

Genovese MC, Cohen SB, Wofsy D, Weinblatt ME, Firestein GS, Brahn E, Strand V, Baker DG, Tong SE. Genovese MC, et al. Among authors: strand v. J Rheumatol. 2011 May;38(5):846-54. doi: 10.3899/jrheum.100602. Epub 2011 Feb 1. J Rheumatol. 2011. PMID: 21285160 Clinical Trial.

9

A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate.

Mease P, Strand V, Shalamberidze L, Dimic A, Raskina T, Xu LA, Liu Y, Smith J. Mease P, et al. Among authors: strand v. Ann Rheum Dis. 2012 Jul;71(7):1183-9. doi: 10.1136/annrheumdis-2011-200704. Epub 2012 Feb 10. Ann Rheum Dis. 2012. PMID: 22328739 Clinical Trial.

10

Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs.

Strand V, Kremer J, Wallenstein G, Kanik KS, Connell C, Gruben D, Zwillich SH, Fleischmann R. Strand V, et al. Arthritis Res Ther. 2015 Nov 4;17:307. doi: 10.1186/s13075-015-0825-9. Arthritis Res Ther. 2015. PMID: 26530039 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

536 results

Search Page

Filters